{
  "DOI": "10.1007/s10689-021-00286-6",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-021-00286-6",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003ePathogenic germline variants in \u003cjats:italic\u003eBreast cancer susceptibility gene 1\u003c/jats:italic\u003e (\u003cjats:italic\u003eBRCA1\u003c/jats:italic\u003e) predispose carriers to hereditary breast and ovarian cancer (HBOC). Through genetic testing of patients with suspected HBOC an increasing number of novel \u003cjats:italic\u003eBRCA1\u003c/jats:italic\u003e variants are discovered. This creates a growing need to determine the clinical significance of these variants through correct classification (class 1–5) according to established guidelines. Here we present a joint collection of all \u003cjats:italic\u003eBRCA1\u003c/jats:italic\u003e variants of class 2–5 detected in the four diagnostic genetic laboratories in Norway. The overall objective of the study was to generate an overview of all \u003cjats:italic\u003eBRCA1\u003c/jats:italic\u003e variants in Norway and unveil potential discrepancies in variant interpretation between the hospitals, serving as a quality control at the national level. For a subset of variants, we also assessed the change in classification over a ten-year period with increasing information available. In total, 463 unique \u003cjats:italic\u003eBRCA1\u003c/jats:italic\u003e variants were detected. Of the 126 variants found in more than one hospital, 70% were interpreted identically, while 30% were not. The differences in interpretation were mainly by one class (class 2/3 or 4/5), except for one larger discrepancy (class 3/5) which could affect the clinical management of patients. After a series of digital meetings between the participating laboratories to disclose the cause of disagreement for all conflicting variants, the discrepancy rate was reduced to 10%. This illustrates that variant interpretation needs to be updated regularly, and that data sharing and improved national inter-laboratory collaboration greatly improves the variant classification and hence increases the accuracy of cancer risk assessment.\u003c/jats:p\u003e",
  "alternative-id": [
    "286"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "3 July 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "3 December 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "4 January 2022"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The study was approved by the Regional Committee for Medical and Health Research Ethics of Haukeland University Hospital (2018/2467)."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-0955-6465",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Hovland",
      "given": "Henrikke N.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Al-Adhami",
      "given": "Rafal",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ariansen",
      "given": "Sarah Louise",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Van Ghelue",
      "given": "Marijke",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sjursen",
      "given": "Wenche",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lima",
      "given": "Sigrid",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bolstad",
      "given": "Marte",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Berger",
      "given": "Amund H.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Høberg-Vetti",
      "given": "Hildegunn",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Knappskog",
      "given": "Per",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Haukanes",
      "given": "Bjørn Ivar",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Aukrust",
      "given": "Ingvild",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-4775-0661",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Ognedal",
      "given": "Elisabet",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        1,
        4
      ]
    ],
    "date-time": "2022-01-04T03:02:33Z",
    "timestamp": 1641265353000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        11,
        4
      ]
    ],
    "date-time": "2022-11-04T10:55:06Z",
    "timestamp": 1667559306000
  },
  "funder": [
    {
      "DOI": "10.13039/501100005029",
      "award": [
        "F-10199/4800001941"
      ],
      "doi-asserted-by": "publisher",
      "name": "helse vest regionalt helseføretak"
    },
    {
      "name": "University of Bergen"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        4,
        21
      ]
    ],
    "date-time": "2023-04-21T22:07:17Z",
    "timestamp": 1682114837505
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2022,
        1,
        4
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2022,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            1,
            4
          ]
        ],
        "date-time": "2022-01-04T00:00:00Z",
        "timestamp": 1641254400000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            1,
            4
          ]
        ],
        "date-time": "2022-01-04T00:00:00Z",
        "timestamp": 1641254400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00286-6.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-021-00286-6/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00286-6.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "389-398",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2022,
        1,
        4
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        1,
        4
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1093/jnci/djw302",
      "doi-asserted-by": "crossref",
      "key": "286_CR1",
      "unstructured": "Kuchenbaecker KB, et al (2017) Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers"
    },
    {
      "key": "286_CR2",
      "unstructured": "The ClinVar Database. 11.09.20. https://www.ncbi.nlm.nih.gov/clinvar/?term=BRCA1%5Bgene%5D."
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "issue": "5",
      "journal-title": "Genet Med",
      "key": "286_CR3",
      "unstructured": "Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–423",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1002/humu.20880",
      "author": "SE Plon",
      "doi-asserted-by": "publisher",
      "first-page": "1282",
      "issue": "11",
      "journal-title": "Hum Mutat",
      "key": "286_CR4",
      "unstructured": "Plon SE et al (2008) Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29(11):1282–1291",
      "volume": "29",
      "year": "2008"
    },
    {
      "key": "286_CR5",
      "unstructured": "ENIGMA Classification Criteria. 11.09.20. https://enigmaconsortium.org/library/general-documents/enigma-classification-criteria/."
    },
    {
      "key": "286_CR6",
      "unstructured": "The Norwegian Breast Cancer Group. Nasjonalt handlingsprogram med retningslinjer diagnostikk, behandling og oppfølging av pasienter med brystkreft, 13th edition. 11.09.2020. https://www.helsedirektoratet.no/retningslinjer/brystkreft-handlingsprogram."
    },
    {
      "DOI": "10.1007/s12325-016-0281-1",
      "author": "DM Eccles",
      "doi-asserted-by": "publisher",
      "first-page": "129",
      "issue": "2",
      "journal-title": "Adv Ther",
      "key": "286_CR7",
      "unstructured": "Eccles DM et al (2016) Selecting patients with ovarian cancer for germline BRCA mutation testing: findings from guidelines and a systematic literature review. Adv Ther 33(2):129–150",
      "volume": "33",
      "year": "2016"
    },
    {
      "key": "286_CR8",
      "unstructured": "National Comprehensive Cancer Network. NCCN Guideliner Genetics/familial High-Risk Assessment: Breast, Ovarian and Pancreatic, version 1.2020. 11.09.20. https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf."
    },
    {
      "DOI": "10.1016/j.ajhg.2016.06.001",
      "doi-asserted-by": "crossref",
      "key": "286_CR9",
      "unstructured": "Amendola, Laura M, et al (2016) Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the clinical sequencing exploratory research consortium. Am J Hum Genet 99(1):247–247."
    },
    {
      "DOI": "10.1200/JCO.2016.68.4316",
      "author": "J Balmaña",
      "doi-asserted-by": "publisher",
      "first-page": "4071",
      "issue": "34",
      "journal-title": "J Clin Oncol",
      "key": "286_CR10",
      "unstructured": "Balmaña J et al (2016) Conflicting interpretation of genetic variants and cancer risk by commercial laboratories as assessed by the prospective registry of multiplex testing. J Clin Oncol 34(34):4071–4078",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.1038/gim.2017.80",
      "author": "MS Lebo",
      "doi-asserted-by": "publisher",
      "first-page": "294",
      "issue": "3",
      "journal-title": "Genet Med",
      "key": "286_CR11",
      "unstructured": "Lebo MS et al (2017) Data sharing as a national quality improvement program: reporting on BRCA1 and BRCA2 variant-interpretation comparisons through the Canadian Open Genetics Repository (COGR). Genet Med 20(3):294–302",
      "volume": "20",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s12687-015-0220-x",
      "author": "PJ Vail",
      "doi-asserted-by": "publisher",
      "first-page": "351",
      "issue": "4",
      "journal-title": "J Community Genet",
      "key": "286_CR12",
      "unstructured": "Vail PJ et al (2015) Comparison of locus-specific databases for BRCA1 and BRCA2 variants reveals disparity in variant classification within and among databases. J Community Genet 6(4):351–359",
      "volume": "6",
      "year": "2015"
    },
    {
      "key": "286_CR13",
      "unstructured": "Dagens medisin 11.09.20. https://www.dagensmedisin.no/artikler/2017/02/17/21-kvinner-fikk-fjernet-bryst-og-eggstokker--skulle-ikke-vart-operert/."
    },
    {
      "DOI": "10.1186/s13053-018-0093-1",
      "author": "P Møller",
      "doi-asserted-by": "publisher",
      "first-page": "10",
      "issue": "1",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "286_CR14",
      "unstructured": "Møller P, Hovig E (2018) Retraction note to: the BRCA2 variant c.68–7 T \u003e A is associated with breast cancer. Hered Cancer Clin Pract 16(1):10–10",
      "volume": "16",
      "year": "2018"
    },
    {
      "key": "286_CR15",
      "unstructured": "HGVS. 14.09.20. https://varnomen.hgvs.org/."
    },
    {
      "DOI": "10.1007/978-3-319-24277-4_12",
      "doi-asserted-by": "crossref",
      "key": "286_CR16",
      "unstructured": "Wickham H (2016) Programming with ggplot2. Springer, Cham, 241–253"
    },
    {
      "DOI": "10.21105/joss.01686",
      "author": "H Wickham",
      "doi-asserted-by": "publisher",
      "first-page": "1686",
      "issue": "43",
      "journal-title": "J Open Source Softw",
      "key": "286_CR17",
      "unstructured": "Wickham H et al (2019) Welcome to the Tidyverse. J Open Source Softw 4(43):1686",
      "volume": "4",
      "year": "2019"
    },
    {
      "key": "286_CR18",
      "unstructured": "Alamut. 14.09.20. http://www.interactive-biosoftware.com/alamut-visual/."
    },
    {
      "key": "286_CR19",
      "unstructured": "GnomAD. 14.09.20. http://gnomad.broad institute.org/."
    },
    {
      "DOI": "10.3390/cancers11020132",
      "author": "P Møller",
      "doi-asserted-by": "publisher",
      "first-page": "132",
      "issue": "2",
      "journal-title": "Cancers (Basel)",
      "key": "286_CR20",
      "unstructured": "Møller P et al (2019) Causes for frequent pathogenic BRCA1 variants include low penetrance in fertile ages, recurrent de-novo mutations and genetic drift. Cancers (Basel) 11(2):132",
      "volume": "11",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s13053-017-0085-6",
      "author": "C Heramb",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "issue": "1",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "286_CR21",
      "unstructured": "Heramb C et al (2018) BRCA1 and BRCA2 mutation spectrum—an update on mutation distribution in a large cancer genetics clinic in Norway. Hered Cancer Clin Pract 16(1):3–15",
      "volume": "16",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s10689-016-9916-2",
      "author": "E Jarhelle",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Fam Cancer",
      "key": "286_CR22",
      "unstructured": "Jarhelle E et al (2017) Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort. Fam Cancer 16(1):1–16",
      "volume": "16",
      "year": "2017"
    },
    {
      "key": "#cr-split#-286_CR23.1",
      "unstructured": "Møller P, et al (2020) Correction: Møller, P."
    },
    {
      "DOI": "10.3390/cancers12020410",
      "doi-asserted-by": "crossref",
      "key": "#cr-split#-286_CR23.2",
      "unstructured": "et al. Causes for frequent pathogenic BRCA1 variants include low penetrance in fertile ages, recurrent de-novo mutations and genetic drift. Cancers 2019, 11, 132. Cancers (Basel) 12(2):410."
    },
    {
      "DOI": "10.1016/S0959-8049(01)00299-4",
      "author": "P Møller",
      "doi-asserted-by": "publisher",
      "first-page": "2428",
      "issue": "18",
      "journal-title": "Eur J Cancer",
      "key": "286_CR24",
      "unstructured": "Møller P et al (2001) Genetic epidemiology of BRCA1 mutations in Norway. Eur J Cancer 37(18):2428–2434",
      "volume": "37",
      "year": "2001"
    },
    {
      "DOI": "10.1136/jmedgenet-2021-107738",
      "doi-asserted-by": "crossref",
      "key": "286_CR25",
      "unstructured": "Mighton C, et al (2021) Data sharing to improve concordance in variant interpretation across laboratories: results from the Canadian Open Genetics Repository. J Med Genet"
    },
    {
      "DOI": "10.1056/NEJMsr1406261",
      "author": "HL Rehm",
      "doi-asserted-by": "publisher",
      "first-page": "2235",
      "issue": "23",
      "journal-title": "N Engl J Med",
      "key": "286_CR26",
      "unstructured": "Rehm HL et al (2015) ClinGen—the clinical genome resource. N Engl J Med 372(23):2235–2242",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1038/gim.2017.60",
      "author": "S Yang",
      "doi-asserted-by": "publisher",
      "first-page": "1118",
      "issue": "10",
      "journal-title": "Genet Med",
      "key": "286_CR27",
      "unstructured": "Yang S et al (2017) Sources of discordance among germ-line variant classifications in ClinVar. Genet Med 19(10):1118–1126",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ajhg.2016.02.024",
      "doi-asserted-by": "crossref",
      "key": "286_CR28",
      "unstructured": "Maxwell, Kara N, et al (2016) Evaluation of ACMG-guideline-based variant classification of cancer susceptibility and non-cancer-associated genes in families affected by breast cancer. Am J Hum Genet 98(5):801–817."
    },
    {
      "DOI": "10.1093/jnci/djn442",
      "author": "TR Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "80",
      "issue": "2",
      "journal-title": "J Natl Cancer Inst",
      "key": "286_CR29",
      "unstructured": "Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers. J Natl Cancer Inst 101(2):80–87",
      "volume": "101",
      "year": "2009"
    },
    {
      "DOI": "10.1093/jnci/djt095",
      "author": "N Mavaddat",
      "doi-asserted-by": "publisher",
      "first-page": "812",
      "issue": "11",
      "journal-title": "J Natl Cancer Inst",
      "key": "286_CR30",
      "unstructured": "Mavaddat N et al (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105(11):812–822",
      "volume": "105",
      "year": "2013"
    },
    {
      "DOI": "10.1136/jmedgenet-2013-101974",
      "author": "RM Brohet",
      "doi-asserted-by": "publisher",
      "first-page": "98",
      "issue": "2",
      "journal-title": "J Med Genet",
      "key": "286_CR31",
      "unstructured": "Brohet RM et al (2014) Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. J Med Genet 51(2):98–107",
      "volume": "51",
      "year": "2014"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-11-1196",
      "author": "E Heijnsdijk",
      "doi-asserted-by": "publisher",
      "first-page": "1458",
      "issue": "9",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "286_CR32",
      "unstructured": "Heijnsdijk E et al (2012) Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI Screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev 21(9):1458–1468",
      "volume": "21",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10549-014-2931-9",
      "author": "ED Gareth",
      "doi-asserted-by": "publisher",
      "first-page": "663",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "286_CR33",
      "unstructured": "Gareth ED et al (2014) MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Res Treat 145(3):663–672",
      "volume": "145",
      "year": "2014"
    },
    {
      "DOI": "10.1200/JCO.2004.04.188",
      "author": "TR Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "1055",
      "issue": "6",
      "journal-title": "J Clin Oncol",
      "key": "286_CR34",
      "unstructured": "Rebbeck TR et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s10549-013-2765-x",
      "author": "SL Ingham",
      "doi-asserted-by": "publisher",
      "first-page": "611",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "286_CR35",
      "unstructured": "Ingham SL et al (2013) Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral. Breast Cancer Res Treat 142(3):611–618",
      "volume": "142",
      "year": "2013"
    },
    {
      "DOI": "10.1093/annonc/mdt384",
      "doi-asserted-by": "crossref",
      "key": "286_CR36",
      "unstructured": "Lee JM, Ledermann JA, Kohn EC (2014) PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies. Ann Oncol 25(1):32–40."
    },
    {
      "DOI": "10.1056/NEJMoa1706450",
      "author": "M Robson",
      "doi-asserted-by": "publisher",
      "first-page": "523",
      "issue": "6",
      "journal-title": "N Engl J Med",
      "key": "286_CR37",
      "unstructured": "Robson M et al (2017) Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med 377(6):523–533",
      "volume": "377",
      "year": "2017"
    },
    {
      "DOI": "10.1056/NEJMoa1105535",
      "author": "J Ledermann",
      "doi-asserted-by": "publisher",
      "first-page": "1382",
      "issue": "15",
      "journal-title": "N Engl J Med",
      "key": "286_CR38",
      "unstructured": "Ledermann J et al (2012) Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. N Engl J Med 366(15):1382–1392",
      "volume": "366",
      "year": "2012"
    },
    {
      "DOI": "10.1056/NEJMoa1903387",
      "author": "T Golan",
      "doi-asserted-by": "publisher",
      "first-page": "317",
      "issue": "4",
      "journal-title": "N Engl J Med",
      "key": "286_CR39",
      "unstructured": "Golan T et al (2019) Maintenance olaparib for germline BRCA -mutated metastatic pancreatic cancer. N Engl J Med 381(4):317–327",
      "volume": "381",
      "year": "2019"
    },
    {
      "DOI": "10.1200/JCO.2014.56.2728",
      "author": "B Kaufman",
      "doi-asserted-by": "publisher",
      "first-page": "244",
      "issue": "3",
      "journal-title": "J Clin Oncol",
      "key": "286_CR40",
      "unstructured": "Kaufman B et al (2015) Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation. J Clin Oncol 33(3):244–250",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1093/annonc/mdz192",
      "author": "J Mateo",
      "doi-asserted-by": "publisher",
      "first-page": "1437",
      "issue": "9",
      "journal-title": "Ann Oncol",
      "key": "286_CR41",
      "unstructured": "Mateo J et al (2019) A decade of clinical development of PARP inhibitors in perspective. Ann Oncol 30(9):1437–1447",
      "volume": "30",
      "year": "2019"
    },
    {
      "DOI": "10.1136/jmedgenet-2019-106759",
      "author": "A Garrett",
      "doi-asserted-by": "publisher",
      "first-page": "829",
      "issue": "12",
      "journal-title": "J Med Genet",
      "key": "286_CR42",
      "unstructured": "Garrett A et al (2020) Cancer variant interpretation group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network. J Med Genet 57(12):829–834",
      "volume": "57",
      "year": "2020"
    },
    {
      "DOI": "10.14735/amko2019S51",
      "doi-asserted-by": "crossref",
      "key": "286_CR43",
      "unstructured": "Machackova E, et al (2019) Twenty years of BRCA1 and BRCA2 molecular analysis at MMCI: current developments for the classification of variants."
    },
    {
      "DOI": "10.1136/jmedgenet-2018-105565",
      "author": "J-S Lee",
      "doi-asserted-by": "publisher",
      "first-page": "794",
      "issue": "12",
      "journal-title": "J Med Genet",
      "key": "286_CR44",
      "unstructured": "Lee J-S et al (2018) Reclassification of BRCA1 and BRCA2 variants of uncertain significance: a multifactorial analysis of multicentre prospective cohort. J Med Genet 55(12):794–802",
      "volume": "55",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41436-019-0493-2",
      "author": "C Mighton",
      "doi-asserted-by": "publisher",
      "first-page": "2248",
      "issue": "10",
      "journal-title": "Genet Med",
      "key": "286_CR45",
      "unstructured": "Mighton C et al (2019) Variant classification changes over time in BRCA1 and BRCA2. Genet Med 21(10):2248–2254",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1097/GIM.0b013e318226fc15",
      "author": "ML Murray",
      "doi-asserted-by": "publisher",
      "first-page": "998",
      "issue": "12",
      "journal-title": "Genet Med",
      "key": "286_CR46",
      "unstructured": "Murray ML et al (2011) Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions. Genet Med 13(12):998–1005",
      "volume": "13",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s00404-017-4631-2",
      "author": "K Kast",
      "doi-asserted-by": "publisher",
      "first-page": "279",
      "issue": "2",
      "journal-title": "Arch Gynecol Obstet",
      "key": "286_CR47",
      "unstructured": "Kast K, Wimberger P, Arnold N (2018) Changes in classification of genetic variants in BRCA1 and BRCA2. Arch Gynecol Obstet 297(2):279–280",
      "volume": "297",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41436-018-0063-z",
      "author": "SA Turner",
      "doi-asserted-by": "publisher",
      "first-page": "426",
      "issue": "2",
      "journal-title": "Genet Med",
      "key": "286_CR48",
      "unstructured": "Turner SA et al (2018) The impact of variant classification on the clinical management of hereditary cancer syndromes. Genet Med 21(2):426–430",
      "volume": "21",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2017.207",
      "author": "S Macklin",
      "doi-asserted-by": "publisher",
      "first-page": "346",
      "issue": "3",
      "journal-title": "Genet Med",
      "key": "286_CR49",
      "unstructured": "Macklin S et al (2017) Observed frequency and challenges of variant reclassification in a hereditary cancer clinic. Genet Med 20(3):346–350",
      "volume": "20",
      "year": "2017"
    }
  ],
  "reference-count": 50,
  "references-count": 50,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-021-00286-6"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "21"
}